GLP-1 and similar medications have revolutionised weight management and emerging research continues to discover a plethora of health benefits. There is a vast potential to improve patient outcomes in cardiovascular health, immune function, cognition and brain function. The emerging research demonstrates new opportunities for natural healthcare practitioners to expand their clinical insights and scope of practice.

These medications are not without their challenges, and for many come at a cost. Effects and compliance issues such as high attrition rates, variable patient response, concerning loss of lean muscle, and significant gastrointestinal distress, further underscore the need for a whole-person practitioner approach.

We are at the tip of the iceberg with this revolution of incretin and other endocrine mimetics. Innovations into incretins and peptides derived from gut, muscle, bone and brain are showing synergistic effects with the ‘traditional’ GLP-1 receptor agonists, highlighting the need for healthcare practitioners to be aware of the growing landscape of therapies and potential mechanisms.  

Join us to discover: